Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Malignant Melanoma

  Free Subscription


14.09.2020

2 Ann Surg Oncol
1 BMC Cancer
2 Br J Dermatol
1 Cancer Lett
1 J Am Acad Dermatol
2 J Invest Dermatol
6 Melanoma Res
1 Nat Med
1 Ophthalmol Retina
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. BEASLEY GM
    Melanomas of Unknown Primary May Have a Distinct Molecular Classification to Explain Differences in Patient Outcomes.
    Ann Surg Oncol. 2020 Sep 10. pii: 10.1245/s10434-020-09114.
    PubMed        

  2. DE ANDRADE JP, Wong P, O'Leary MP, Parekh V, et al
    Multidisciplinary Care for Melanoma of Unknown Primary: Experience in the Era of Molecular Profiling.
    Ann Surg Oncol. 2020 Sep 9. pii: 10.1245/s10434-020-09112.
    PubMed         Abstract available


    BMC Cancer

  3. SU W, Guan Y, Huang B, Wang J, et al
    Bioinformatic analysis reveals hub genes and pathways that promote melanoma metastasis.
    BMC Cancer. 2020;20:863.
    PubMed         Abstract available


    Br J Dermatol

  4. MIRZA FN, Yumeen S, Walter FM
    The Epidemiology of Malignant Melanoma, Squamous Cell Carcinoma, and Basal Cell Carcinoma in the United Kingdom from 2004-2014: A Population-Based Cohort Analysis using the Clinical Practice Research Datalink.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19542.
    PubMed         Abstract available

  5. ELSARAFY S, Tobiss H, Veitch D, Bhuchar M, et al
    Ruptured hair follicles of the scalp mimicking malignant melanoma.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19476.
    PubMed        


    Cancer Lett

  6. SMALLEY H, Rowe JM, Nieto F, Zeledon J, et al
    Beta2 glycoprotein I-derived therapeutic peptides induce sFlt-1 secretion to reduce melanoma vascularity and growth.
    Cancer Lett. 2020 Sep 3. pii: S0304-3835(20)30453.
    PubMed         Abstract available


    J Am Acad Dermatol

  7. RYU GW, Choi YD, Ryu YJ, Lee JB, et al
    Risk Factors Affecting the First Metastasis of Acral Melanoma: Low-pigmentation Independently Predicts a First Lung Metastasis.
    J Am Acad Dermatol. 2020 Sep 3. pii: S0190-9622(20)32535.
    PubMed        


    J Invest Dermatol

  8. ZHANG C, Smalley I, Emmons MF, Sharma R, et al
    Non-canonical EphA2 signaling is a driver of tumor-endothelial cell interactions and metastatic dissemination in BRAF inhibitor resistant melanoma.
    J Invest Dermatol. 2020 Sep 2. pii: S0022-202X(20)32047.
    PubMed         Abstract available

  9. LEE B, Sahoo A, Sawada J, Marchica J, et al
    MicroRNA-211 modulates the DUSP6-ERK5 signaling axis to promote BRAF(V600E)-driven melanoma growth in vivo and BRAF/MEK inhibitor resistance.
    J Invest Dermatol. 2020 Sep 1. pii: S0022-202X(20)32043.
    PubMed         Abstract available


    Melanoma Res

  10. VELTER C, Marzouki-Zerouali A, Robert C
    Is it melanoma? Ask my dog!
    Melanoma Res. 2020;30:529-530.
    PubMed        

  11. SENGUL SAMANCI N, Celik E, Bagcilar O, Erol BC, et al
    Loss of skeletal muscle area and fat-free mass during dabrafenib/trametinib and vemurafenib/cobimetinib treatments in patients with BRAF-mutant metastatic malignant melanoma.
    Melanoma Res. 2020;30:477-483.
    PubMed         Abstract available

  12. DIAMANTOPOULOS PT, Tsatsou K, Benopoulou O, Bonou M, et al
    Concomitant development of neurologic and cardiac immune-related adverse effects in patients treated with immune checkpoint inhibitors for melanoma.
    Melanoma Res. 2020;30:484-491.
    PubMed         Abstract available

  13. CAINI S, Gandini S, Botta F, Tagliabue E, et al
    MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project.
    Melanoma Res. 2020;30:500-510.
    PubMed         Abstract available

  14. SHIN J, Ho Lee D, Lee WJ, Park CS, et al
    Mycosis fungoides development after combined immune checkpoint blockade therapy in a patient with malignant melanoma: a case report.
    Melanoma Res. 2020;30:515-518.
    PubMed         Abstract available

  15. KEUKELEIRE S, Schwarze J, Awada G, Everaert H, et al
    An atypical sarcoid-like reaction during anti-protein death 1 treatment in a patient with metastatic melanoma.
    Melanoma Res. 2020;30:524-527.
    PubMed         Abstract available


    Nat Med

  16. LIU Y, Jain A, Eng C, Way DH, et al
    A deep learning system for differential diagnosis of skin diseases.
    Nat Med. 2020;26:900-908.
    PubMed         Abstract available


    Ophthalmol Retina

  17. ROELOFS KA, Fabian ID, Arora AK, Cohen VML, et al
    Long term outcomes of small pigmented choroidal melanoma treated with primary photodynamic therapy.
    Ophthalmol Retina. 2020 Sep 2. pii: S2468-6530(20)30363.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  18. TAN J, Liu R, Zhu G, Umbricht CB, et al
    TERT promoter mutation determines apoptotic and therapeutic responses of BRAF-mutant cancers to BRAF and MEK inhibitors: Achilles Heel.
    Proc Natl Acad Sci U S A. 2020;117:15846-15851.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: